• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    Impax Laboratories Inc. (IPXL)

    -NasdaqGS
    38.83 Jan 26, 4:00PM EST
    Add to Portfolio
    Prev Close:38.83
    Open:N/A
    Bid:34.11 x 100
    Ask:39.95 x 2000
    1y Target Est:34.15
    Beta:1.82
    Earnings Date:Feb 18 - Feb 23 (Est.)
    Day's Range:N/A - N/A
    52wk Range:21.34 - 38.91
    Volume:0
    Avg Vol (3m):655,300
    Market Cap:2.65B
    P/E (ttm):57.78
    EPS (ttm):0.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IPXL 0.00%2.65B
    MYL21.26B
    TEVA50.43B

    Key Statistics

    Forward P/E (1 yr):23.25
    P/S (ttm):4.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :1.29
    Quarterly EPS Est (Dec-14) :0.12
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):1.72

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products; and develops and markets branded products. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback